Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Federated Hermes Kaufmann Small Cap Fund | 5.46% | 2.9M | 5.8M |
| Federated Hermes Kaufmann Fund | 4.26% | 2.27M | 4.53M |
| Fidelity Select Portfolios - Biotechnology | 4.25% | 2.26M | 4.52M |
| Fidelity Growth Company Fund | 3.35% | 1.78M | 3.56M |
| Vanguard Total Stock Market Index Fund | 1.39% | 737.93k | 1.48M |
| Fidelity Growth Company K6 Fund | 1.15% | 609.7k | 1.22M |
| Fidelity Series Growth Company Fund | 0.89% | 470.83k | 941.66k |
| Vanguard Extended Market Index Fund | 0.66% | 353.29k | 706.57k |
| Fidelity Extended Market Index Fund | 0.27% | 142.68k | 285.35k |
| DFA U.S. Small Cap Series | 0.18% | 97.54k | 195.08k |
aTyr Pharma Announces Nasdaq Stock Ticker Symbol Change from “LIFE” to “ATYR”
06/03 08:00 am
GlobeNewswire Inc.
Read moreaTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05/24 04:00 pm
GlobeNewswire Inc.
Read moreWall Street Breakfast: The Week Ahead
05/19 06:35 am
Seeking Alpha
Read moreaTyr Pharma to Present Poster Describing Efzofitimod’s Mechanism of Action at the American Thoracic Society 2024 International Conference
05/15 07:00 am
GlobeNewswire Inc.
Read moreaTyr Pharma Announces Second Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis
05/14 08:00 am
GlobeNewswire Inc.
Read moreaTyr Pharma Announces First Quarter 2024 Results and Provides Corporate Update
05/02 04:00 pm
GlobeNewswire Inc.
Read moreaTyr Pharma to Participate in April Investor Conferences
04/01 08:00 am
GlobeNewswire Inc.
Read moreaTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update
03/14 04:00 pm
GlobeNewswire Inc.
Read moreEditas Medicine (EDIT) Reports Q4 Loss, Tops Revenue Estimates
02/28 09:10 am
Zacks Investment Research
Read moreaTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2023 Financial Results
02/28 09:00 am
GlobeNewswire Inc.
Read moreaTyr Pharma Presents Poster Demonstrating Preclinical Effects of Efzofitimod in Rheumatoid Arthritis and Rheumatoid Arthritis-Associated ILD at the ACR Convergence 2023
11/13 09:00 am
GlobeNewswire Inc.
Read moreaTyr Pharma Announces Third Quarter 2023 Results and Provides Corporate Update
11/09 05:00 pm
GlobeNewswire Inc.
Read moreAnalyst Expectations for aTyr Pharma's Future
09/21 12:00 pm
Benzinga
Read moreaTyr Pharma Presents Efzofitimod Data Demonstrating Statistically Significant Improvements in Time to Relapse, FVC and Patient Reported Outcomes
09/11 08:00 am
GlobeNewswire Inc.
Read more5 Top Stocks to Play Earnings Beat Potential
09/04 07:30 am
Zacks Investment Research
Read moreDown -9.64% in 4 Weeks, Here's Why You Should You Buy the Dip in Atyr Pharma (LIFE)
08/30 09:35 am
Zacks Investment Research
Read moreaTyr Pharma to Present at the H.C. Wainwright 25th Annual Global Investment Conference
08/24 08:00 am
GlobeNewswire Inc.
Read more5 Top Stocks Likely to Top Earnings Estimates
08/18 07:49 am
Zacks Investment Research
Read moreAtyr Pharma (LIFE) Reports Q2 Loss, Lags Revenue Estimates
08/09 05:30 pm
Zacks Investment Research
Read moreaTyr Pharma Announces Second Quarter 2023 Results and Provides Corporate Update
08/09 04:00 pm
GlobeNewswire Inc.
Read more$12M Bet On This Trucking Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
08/02 09:06 am
Benzinga
Read moreaTyr Pharma's Cash Runway Secured till 2026, Despite Lack of Material Catalysts: Oppenheimer Analyst
07/05 03:35 pm
Benzinga
Read moreBenzinga's Top Ratings Upgrades, Downgrades For July 5, 2023
07/05 11:02 am
Benzinga
Read moreaTyr Pharma to Present on Lead Therapeutic Candidate Efzofitimod at the World Association for Sarcoidosis and Other Granulomatous Disorders (WASOG) Conference
06/20 08:00 am
GlobeNewswire Inc.
Read moreaTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06/09 04:00 pm
GlobeNewswire Inc.
Read moreaTyr Pharma to Present at the 2023 Jefferies Healthcare Conference
05/25 08:00 am
GlobeNewswire Inc.
Read moreThe Latest Analyst Ratings for aTyr Pharma
05/23 04:01 pm
Benzinga
Read moreAtyr Pharma (LIFE) Reports Q1 Loss, Misses Revenue Estimates
05/09 05:15 pm
Zacks Investment Research
Read moreWhere aTyr Pharma Stands With Analysts
03/10 11:01 am
Benzinga
Read moreAtyr Pharma (LIFE) Reports Q4 Loss, Tops Revenue Estimates
03/09 06:15 pm
Zacks Investment Research
Read moreaTyr Pharma Announces Fourth Quarter and Full Year 2022 Results and Provides Corporate Update
03/09 05:00 pm
GlobeNewswire Inc.
Read moreaTyr Pharma to Present at March Investor Conferences
03/08 09:00 am
GlobeNewswire Inc.
Read moreAtyr Pharma (LIFE) Upgraded to Buy: Here's What You Should Know
02/17 01:00 pm
Zacks Investment Research
Read moreaTyr Pharma Announces Commencement of Public Offering of Common Stock
02/08 05:11 pm
GlobeNewswire Inc.
Read moreaTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/18 05:00 pm
GlobeNewswire Inc.
Read moreAtyr Pharma (LIFE) Reports Q3 Loss, Lags Revenue Estimates
11/10 06:15 pm
Zacks Investment Research
Read moreaTyr Pharma to Present at Upcoming Investor Conferences
11/10 09:00 am
GlobeNewswire Inc.
Read moreaTyr Pharma to Webcast Conference Call Reporting Third Quarter 2022 Financial Results
11/03 08:02 am
GlobeNewswire Inc.
Read moreNexImmune Price Target Cut By 75%, Plus Wells Fargo Lowers PT Price Target On These Stocks
08/16 07:49 am
Benzinga
Read moreaTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08/12 04:05 pm
GlobeNewswire Inc.
Read moreaTyr Pharma Receives FDA Fast Track Designation for Efzofitimod (ATYR1923) for Treatment of Pulmonary Sarcoidosis
08/11 08:03 am
GlobeNewswire Inc.
Read moreBest Penny Stocks to Buy Now According To 3 Top Analysts
07/21 11:59 am
PennyStocks
Read moreSnap to $25? Plus This Analyst Cuts Price Target On Amazon.com
07/21 08:43 am
Benzinga
Read more$1.4 Million Bet On This Healthcare Stock? 4 Penny Stocks Insiders are Buying
07/07 08:16 am
Benzinga
Read moreaTyr Pharma Announces FGFR4 as Receptor Target for AARS tRNA Synthetase Fragment
06/14 08:00 am
GlobeNewswire Inc.
Read moreaTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05/13 04:00 pm
GlobeNewswire Inc.
Read moreAtyr Pharma (LIFE) Reports Q1 Loss, Misses Revenue Estimates
05/09 05:15 pm
Zacks Investment Research
Read moreaTyr Pharma (LIFE) Up on Orphan Drug Status for Efzofitimod
04/14 12:14 pm
Zacks Investment Research
Read moreaTyr Pharma Announces FDA Orphan Drug Designation for Efzofitimod (ATYR1923) for Treatment of Systemic Sclerosis
04/13 08:00 am
GlobeNewswire Inc.
Read moreaTyr Pharma to Present Clinical Data for Efzofitimod (ATYR1923) at the American Thoracic Society 2022 International Conference
04/01 08:00 am
GlobeNewswire Inc.
Read more